Schwalb Alvaro, Cachay Rodrigo, Curisinche-Rojas Maricela, Gotuzzo Eduardo, Ríos Julia, Ugarte-Gil César
Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Av. Honorio Delgado 430, San Martin de Porres, 15102 Lima, Peru.
Dirección de Prevención y Control de Tuberculosis, Ministerio de Salud, Av. Horacio Urteaga 900, Jesús María, 15072 Lima, Peru.
J Clin Tuberc Other Mycobact Dis. 2021 Mar 26;23:100232. doi: 10.1016/j.jctube.2021.100232. eCollection 2021 May.
International conferences on tuberculosis (TB) have been held since the 19th century. In Peru, the TB Scientific Conferences have been held annually in Lima since 2013 as a means of developing a national TB research network and setting the stage for researchers and institutions to present and share new findings from studies conducted in Peru.
Systematization of information on speakers and presentations from TB Scientific Conferences in Peru. Presentation files and official agendas for the conferences from 2013 to 2019 were obtained from the Tuberculosis Prevention and Control Directorate's website.
A total of 426 scientific presentations have been delivered by 230 speakers, with a steady annual increase. 37.1% of the talks were given by female speakers. To date, 61.4% of the research presented has been published. Out of all the studies, 10.9% (30/275) were part of international, multicentric research projects. Main research lines were epidemiology (40.1%), drug-resistance (29.6%) and treatment (22.1%).
TB Scientific Conferences serve as a platform to share region-specific TB evidence between local stakeholders (health officials, academics, and others) who aim to facilitate the implementation of measures with the goal of reducing the national gaps towards the End TB Strategy goals.
自19世纪以来,国际结核病会议持续召开。在秘鲁,自2013年起,结核病科学会议每年在利马举行,以此建立全国结核病研究网络,并为研究人员和机构提供一个平台,以便展示和分享在秘鲁开展的研究中的新发现。
对秘鲁结核病科学会议上发言者和演讲内容的信息进行系统化整理。2013年至2019年会议的演讲文件和官方议程来自结核病预防与控制局网站。
230位发言者共发表了426场科学演讲,且数量逐年稳步增长。37.1%的演讲由女性发言者进行。截至目前,所展示研究的61.4%已发表。在所有研究中,10.9%(30/275)属于国际多中心研究项目。主要研究方向为流行病学(40.1%)、耐药性(29.6%)和治疗(22.1%)。
结核病科学会议为当地利益相关者(卫生官员、学者等)提供了一个分享特定地区结核病证据的平台,这些利益相关者旨在推动各项措施的实施,以缩小国家与终结结核病战略目标之间的差距。